dissemination – Page 40 – Communicable Diseases Research

SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event

3개국 도시 지역에서 발생한 SARS-CoV-2 발병은 대규모 모임 이벤트와 연결된 B.1 계보 변종에 의해 지배됩니다.

Research Article

Published on 2021-03-192022-08-13
Journal: PLoS Pathogens [Category] SARS, 변종, 유전자 메커니즘, 치료기술,

COVID-19 and the teacher’s voice: self-perception and contributions of speech therapy to voice and communication during the pandemic

Original Article

Published on 2021-03-192022-10-31
Journal: Clinics [Category] COVID-19, SARS,

Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic

Immunology

Published on 2021-03-182022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, SARS,

[키워드] barrier Care CDC childhood children Compliance COVID-19 COVID-19 pandemic disease Diseases dissemination distribution effective effort exacerbate Health health information healthcare Hesitancy hygiene immunization implication offer Other outbreak parental pediatric physical distancing Population positioned protocol public health Public health intervention recall recommendation routine SARS-CoV-2 social determinant social determinants of health (SDOH) strained Surveillance the United State uptake vaccination vaccination rates Vaccine vaccine compliance Vaccine confidence vaccine disparity Vaccine hesitancy worsening
[DOI] 10.3389/fimmu.2021.663074 PMC 바로가기 [Article Type] Immunology

Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

Epidemiology

Published on 2021-03-172022-10-28
Journal: BMJ Open [Category] COVID-19,

[키워드] analysed Analysis approval asked behavioural catastrophic caused change city Cohort collected COVID-19 determinant dissemination Epidemiology Ethics evaluate Government host immunity household household transmission immune response Immunity Immunological response immunology Infection initial investigated IRAS nasal swab National Health Service nucleic acid amplification participant Participants peer-reviewed positive Prevalence Prospective prospective observational study protocol public health REC reduce Region respiratory infections restrict Result risk factor SARS-CoV-2 SARS-COV-2 infection secondary attack rate severity Spread spread of COVID-19 Stage Study protocol Symptoms tested the disease Transmission transmission of SARS-CoV-2 variables Virology widespread
[DOI] 10.1136/bmjopen-2020-048317 PMC 바로가기 [Article Type] Epidemiology

COVIDENZA – A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

COVIDENZA - 코로나 바이러스 질병 2019(COVID-19) 환자의 이환율을 감소시키기 위한 엔잘루타미드 치료의 전향적, 다기관, 무작위 PHASE II 임상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-03-162022-09-10
Journal: Trials [Category] SARS, 임상, 치료제,

[키워드] 7-point ordinal scale age androgen Androgen receptor androgen signalling antiandrogen anticipated approved Blinding Breast cancer breast-feeding cardiovascular disease center clinical trial comparator comparator Patients Complete connection Corona virus COVID-19 COVID-19 patient COVID-19 symptom COVID-19 symptoms decrease discharge disease dissemination element enzalutamide enzyme evaluate exclusion criteria expression FIVE focus followed by for inclusion hospital hospitalised host cell Hypothesis Identifier identify immunosuppressive drugs IMPROVE include Inclusion independent intensive care interim analysis Laboratory Major majority male mechanical ventilation men morbidity multicenter multicentre North number objective observation Open-label open-label trial Ordinal Scale outcome participant Participants Patient PCR Placebo power pregnant women primary endpoint primary endpoints PROC Prostate protocol randomisation list randomised randomised controlled trial Randomized receptor Region Registered Sample size SARS-CoV-2 host cell SAS Institute SAS version 9.4 Sex Standard of care status stratified Study protocol subject supplementary material symptomatic Testosterone TMPRSS2 to define treated Treatment treatment arm Trial university Västerbotten website with COVID-19 women
[DOI] 10.1186/s13063-021-05137-4 PMC 바로가기 [Article Type] Letter

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study

Article

Published on 2021-03-162022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] 95%CI absence affected age baseline characteristics Cancer cancer patient Chemotherapy cohort study complications confounding variable Corona COVID-19 COVID-19 pandemic Critical data set Desaturation dissemination Dyspnea Effect event Follow-up high risk independent Infection International interstitial pneumonia interval Italian Italy less lombardy management median median age Mortality multicenter Neutral occurred outcome pandemic Patient predictors Prognosis Prognostic factor Ratio receiving recommendations Region remained risk factor risk of death SACT SARS-CoV-2 SARS-COV-2 infection severe COVID-19 simple study population Systemic anti-cancer treatment therapy Treatment vaccination vulnerable patient while
[DOI] 10.3390/cancers13061324 PMC 바로가기 [Article Type] Article

Understanding how communities respond to COVID-19: experiences from the Orthodox Jewish communities of Antwerp city

Research

Published on 2021-03-152022-10-29
Journal: International journal for equity in health [Category] COVID-19,

Precise Transmission for COVID-19 Information: Based on China’s Experience

Article

Published on 2021-03-152022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

Impact of the SARS-CoV-2 (COVID-19) crisis on surgical training: global survey and a proposed framework for recovery

Original Article

Published on 2021-03-152022-10-28
Journal: BJS Open [Category] COVID-19,

International assessment of the link between COVID-19 related attitudes, concerns and behaviours in relation to public health policies: optimising policy strategies to improve health, economic and quality of life outcomes (the iCARE Study)

Public Health

Published on 2021-03-112022-10-28
Journal: BMJ Open [Category] COVID-19,